Discontinuation of Dialysis After ¹⁷⁷Lu-PSMA Therapy in mCRPC With Malignant Obstructive Uropathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41940836.
- Also identified by DOI 10.1097/RLU.0000000000006441.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A major complication of advanced prostate cancer is malignant obstructive uropathy, a condition that can precipitate post-renal acute kidney injury and ultimately require hemodialysis intervention. We present a striking imaging example of a patient with metastatic castration-resistant prostate cancer (mCRPC) and dialysis-dependent renal failure who demonstrated marked tumor regression and discontinuation of dialysis following 177 Lu-PSMA radioligand therapy.
Medical subject headings
- Renal Dialysis
- Prostatic Neoplasms, Castration-Resistant
- Lutetium
- Withholding Treatment